Privacy Officer Tasks With the release of DLM 800, In England, Wales and Northern Ireland, to ensure appropriate governance of actions is maintained, your practice designated Privacy Officer(s) will now receive the following in Daybook or Tasks:
Latest News
When you add a medication, Vision 3 automatically runs specific drug checks depending on your set up. It is important for patient safety that Drug Checks are set up effectively. The Benefits of Automatic Drug Checks guide details the available checks and how to set them up within Vision 3.
updated Coronavirus (COVID-19) Management Guideline, utilising the recently released vaccinations, to support you in caring for your patients.
To ensure your messages are processed in a timely manner, this is a list of checks that your practice should carry out every day
Additional Patient Details from Clinical Audit Updated (24th March 2021)
Tags: Vision 3,Clinical Audit
This specialist Excel spreadsheet allows for any Clinical Audit reports to be exported as csv files, and automatically includes the patient communication details as required.
We are pleased to confirm that the SNOMED CT and Vision Local Codes release 31.3.0 has been released and should be available for use within the next couple of days. Please be advised this release includes new COVID related oximetry terms. See release guide here for details.
As there can be a delay in health boards transferring out deceased patients, there is a chance that you will generate invitations and recalls for them. This can, understandably, be very distressing for the deceased patient’s family. Unfortunately, Clinical Audit cannot look at Registration Links data, so to ensure you do not raise invitations and recalls for your recently deceased patients, you should run a search on the group.
If your practice receives data from Vision Anywhere as part of a federation, cluster or shared service, it is important you do not inactivate the Dr Federated User staff member in Vision 3 Control Panel
• Adult Patients with Down's Syndrome - All adults in England with Down’s Syndrome should be identified and reviewed by practices for inclusion on the Shielded Patient List (SPL). • Stage 5 Chronic Kidney Disease (CKD) – All patients with Stage 5 CKD are being contacted with regards to Coronavirus shielding. For your information the definition of Stage 5 CKD is: • Chronic kidney disease is defined as a reduction in kidney function or structural damage, or both, present for more than 3 months. • CKD stage 5, or G5 A1-3, is defined as a GFR less than 15 ml/min. Note - Stage 5 CKD excludes individuals who transiently drop below 15 ml/min, for example, acute kidney injury, acute on chronic kidney disease. We have updated the Coronavirus clinical audits to support these updates: • Click here for the latest In Practice Systems Daily audit. • Click here for details on how to download audits. NHS Digital have provided us with an updated Shielded Patient letter for your patients who qualify for the SPL and for patients that newly qualify for the SPL based on the above criteria. We have turned these into Vision template letters, which can be downloaded from the following links: • High risk patients - 201104_Highest_risk_additions_letter_1K. • Down’s Syndrome Patients: • Standard - 201104_Highest_risk_additions_letter_Downs_syndrome. • Easy Read - EasyRdLetter_DownSyndrome_Final 02 11 20. Important - We recommend that both Down’s syndrome letters are provided to the patient. • Stage 5 CKD - 201104_Highest_risk_additions_letter_CKD. Remember – These are templates, you can update them to your practice format as required.
NHSX, the team who report directly to the Secretary of State and the Chief Executive of NHS England and NHS Improvement, have launched an online portal that brings together national guidance on information governance in a clear and consistent format. It is aimed at both colleagues working in information governance and frontline staff working in health and care organisations. You can read the NHSX blog about information governance to find out more about the portal.